[{"Assets_0_FY_USD":"962535000.0","CIK":"1576280","CommonStockSharesIssued_0_FY_shares":"94261414.0","CommonStockSharesOutstanding_0_FY_shares":"94261414.0","Country":"United States","EarningsPerShareBasic_4_FY_USD":"-0.84","Industry":"Medical Specialities","Market":"NASDAQ","Market Cap":"7427038249.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":"-47134000.0","NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":"-75651000.0","NetIncomeLoss_4_FY_USD":"-75651000.0","OfficialName":"Guardant Health Inc. Common Stock","ProfitLoss_4_FY_USD":"-67851000.0","RevenuesConverted_4_FY_USD":"214375000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_FY_USD":"798393000.0","Ticker":"GH","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":"90597000.0","filed":"20200302","footnote":"As of December 31, 2019 and 2018, includes $45.1 million and $48.3 million of assets, respectively, that can be used only to settle obligations of the consolidated variable interest entity (VIE) and VIEs subsidiaries, and $5.7 million and $1.2 million of liabilities, respectively, of the consolidated VIE of liabilities of consolidated VIE and VIEs subsidiaries for which their creditors do not have recourse to the general credit of the Company. See Note 3, Investment in Joint Venture. | Fiscal 2018 does","form":"10-K","fp":"FY","fy":"2019.0","name":"GUARDANT HEALTH, INC.","period":"20191231","qtrs":"0","uom":"USD"}]